Viewing Study NCT06345157


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-20 @ 6:30 AM
Study NCT ID: NCT06345157
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2024-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis, Relapsing-Remitting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis, View
None Relapsing-Remitting, View
None RRMS, View
None ofatumumab View